Ionis Pharmaceuticals (IONS) Tops Q1 EPS by 5c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q1 EPS of ($0.98), $0.05 better than the analyst estimate of ($1.03). Revenue for the quarter came in at $119 million versus the consensus estimate of $132.7 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Biogen expects $164M R&D charge to hit Q2 2026 earnings
• Atmos Energy (ATO) PT Lowered to $185 at Argus